The long-term goal of the proposed research is to correlate enteroviral presence in the heart, and perhaps other organs, with causation of acute myocarditis which progresses to chronic myocardial diseases such as dilated cardiomyopathies. The two specific aims of the work are (1) to examine the role of the inducing coxsackievirus B3 and murine genetic backgrounds through in situ hybridization detection of viral RNA in many murine tissues during disease progression following viral innoculation; (2) to sensitively probe human heart tissue and peripheral blood mononuclear cells of clinically well- characterized myocarditis patients and myocardium of explanted dilated hearts for the presence of enteroviral genomes and to develop a rapid, sensitive assay for enteroviral RNA using enzymatic amplication of nucleotide sequences and novel enhanced rate hybridization kinetics capable of detecting in the range of 10-100 enteroviral RNa molecules in biopsy within hours. The mouse model will be employed to determine what effects the virulence of the virus and the host genetic background have on viral persistence, disease progression, and presence of virus in the chronic phase of the disease and to draw inferences to the presumed homologous human situation. These experiments will provide essential data to evaluate whether enteroviruses remain in tissues other than heart following acute infection, perhaps acting as seeds to promote the inflammatory processes which have been demonstrated as deleterious to the heart in chronic disease. Screening of human hearts for enteroviral RNA, by in situ hybridization and later using a more sensitive approach developed in the course of this work, will determine whether enteroviral presence and presence of pathologic changes in the affected human organ can be correlated. Cumulatively, these experiments will determine whether there is justification to pursue prophylactic measures against specific enteroviruses as causes of human myocarditis and cardiomyopathies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL040303-03
Application #
3357398
Study Section
Virology Study Section (VR)
Project Start
1988-04-01
Project End
1991-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Carson, S D; Chapman, N N; Tracy, S M (1997) Purification of the putative coxsackievirus B receptor from HeLa cells. Biochem Biophys Res Commun 233:325-8
Lee, C; Maull, E; Chapman, N et al. (1997) Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. Virus Res 50:225-35
Lee, C; Maull, E; Chapman, N et al. (1997) Genomic regions of coxsackievirus B3 associated with cardiovirulence. J Med Virol 52:341-7
Tracy, S; Chapman, N M; Romero, J et al. (1996) Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol 4:175-9
Tu, Z; Chapman, N M; Hufnagel, G et al. (1995) The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol 69:4607-18
Gauntt, C J; Tracy, S M; Chapman, N et al. (1995) Coxsackievirus-induced chronic myocarditis in murine models. Eur Heart J 16 Suppl O:56-8
Chapman, N M; Tu, Z; Tracy, S et al. (1994) An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch Virol 135:115-30
Beck, M A; Tracy, S; Coller, B A et al. (1992) Comoviruses and enteroviruses share a T cell epitope. Virology 186:238-46
Tracy, S; Chapman, N M; Tu, Z (1992) Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch Virol 122:399-409
Carstens, J M; Tracy, S; Chapman, N M et al. (1992) Detection of enteroviruses in cell cultures by using in situ transcription. J Clin Microbiol 30:25-35

Showing the most recent 10 out of 18 publications